Eastern diet takes on hypertension: can a 3-Month meal plan lower blood pressure?

NCT ID NCT07735091

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether a 3-month dietary program, called the Eastern Blood Pressure-Lowering Diet, can improve blood pressure in Chinese adults with hypertension. About 800 participants from workplace canteens will either receive standard hypertension care or also get specially designed lunches, low-sodium salt, and app-based support. The main goal is to see if the diet reduces resting systolic and diastolic blood pressure compared to standard care alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a culturally adapted blood pressure-lowering dietary pattern called the Eastern Blood Pressure-Lowering Diet, including specially designed weekday lunches, low-sodium salt, reduced-sodium seasonings, and app-based support
What this could lead to
If effective, this diet could offer a practical, non-drug approach to managing hypertension in Chinese adults, potentially reducing the need for medication.
What could go wrong
This is a single trial in a specific workplace setting, so results may not apply to other populations. The diet requires significant lifestyle changes, and long-term adherence may be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sinopec Shengli Petroleum Administrative Bureau Co., Ltd.

    Dongying, Shandong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.